company background image
603998 logo

Hunan Fangsheng Pharmaceutical SHSE:603998 Stock Report

Last Price

CN¥11.10

Market Cap

CN¥5.0b

7D

0.8%

1Y

5.7%

Updated

23 Jul, 2024

Data

Company Financials +

Hunan Fangsheng Pharmaceutical Co., Ltd.

SHSE:603998 Stock Report

Market Cap: CN¥5.0b

Hunan Fangsheng Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hunan Fangsheng Pharmaceutical
Historical stock prices
Current Share PriceCN¥11.10
52 Week HighCN¥13.09
52 Week LowCN¥7.12
Beta0.31
11 Month Change6.12%
3 Month Change-3.39%
1 Year Change5.71%
33 Year Change103.30%
5 Year Change64.44%
Change since IPO26.21%

Recent News & Updates

The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet

Jun 06
The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet

Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders

Apr 30
Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders

Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up

Mar 04
Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up

Recent updates

The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet

Jun 06
The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet

Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders

Apr 30
Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders

Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up

Mar 04
Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up

Shareholder Returns

603998CN PharmaceuticalsCN Market
7D0.8%3.0%0.5%
1Y5.7%-13.4%-16.6%

Return vs Industry: 603998 exceeded the CN Pharmaceuticals industry which returned -13.4% over the past year.

Return vs Market: 603998 exceeded the CN Market which returned -16.6% over the past year.

Price Volatility

Is 603998's price volatile compared to industry and market?
603998 volatility
603998 Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 603998 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603998's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,686Xiaoli Zhouwww.fangsheng.com.cn

Hunan Fangsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for the treatment of orthopedic, cardiovascular and cerebrovascular, anti-infection, pediatric, gynecological, respiratory system, traumatology, and other diseases. The company was founded in 2002 and is based in Changsha, China.

Hunan Fangsheng Pharmaceutical Co., Ltd. Fundamentals Summary

How do Hunan Fangsheng Pharmaceutical's earnings and revenue compare to its market cap?
603998 fundamental statistics
Market capCN¥4.98b
Earnings (TTM)CN¥193.23m
Revenue (TTM)CN¥1.63b

25.3x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603998 income statement (TTM)
RevenueCN¥1.63b
Cost of RevenueCN¥499.01m
Gross ProfitCN¥1.13b
Other ExpensesCN¥937.90m
EarningsCN¥193.23m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)0.44
Gross Margin69.39%
Net Profit Margin11.85%
Debt/Equity Ratio43.1%

How did 603998 perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

66%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.